Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT newswire2026/10/09 14:57

10:57 AM EDT, 10/09/2026 (MT Newswires) -- Moderna (MRNA) and other vaccine developers were up on Friday after The New York Times reported that the National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares were up 5.4% around 10:50 am ET, while shares of Merck (MRK) and Novavax (NVAX) were up 1.7% and 9.2%, respectively. Shares of BioNTech (BNTX), Vaxcyte (PCVX) and Vir Biotechnology (VIR) were up 2.5%, 5.7% and 3.1% (Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 207.71, Change: +10.71, Percent Change: +5.44

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Retail investors return to AI! Citadel Securities: net buying of US stocks reached $9.1 billions last week, third highest chip stock purchases in a year

Retail investors, who once hesitated, are now returning to their favorite bet: artificial intelligence (AI).

智通财经•2026/10/13 22:51

HII wins $56 million US Navy contract for AUKUS submarine design support

Bitget•2026/10/13 22:21

Updated version: Zealand Pharma reaches an AI weight-loss drug deal with Generate valued at up to 1.2 billions USD.

路透社•2026/10/13 22:17

Chinese Yuan: Outlook stays mildly positive against US Dollar – UOB

FXStreet•2026/10/13 21:18